SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-11-000319
Filing Date
2011-05-26
Accepted
2011-05-26 16:55:20
Documents
1
Group Members
DANIEL S. LOEB

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 19 n6657281b.htm SC 13D/A 87158
  Complete submission text file 0000899140-11-000319.txt   89020
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
Type: SC 13D/A | Act: 34 | File No.: 005-31596 | Film No.: 11874949
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 390 PARK AVENUE NEW YORK NY 10022
Business Address 390 PARK AVENUE NEW YORK NY 10022 2122247400
Third Point LLC (Filed by) CIK: 0001040273 (see all company filings)

IRS No.: 133922602 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A